Acompanhe as Notícias da Recifes

Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This may mean that targeting them would be as effective as suppressing the immune system, with fewer side effects

The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and sp

The ongoing evolution of SARS-CoV-2, particularly the rapid emergence of the omicron variant and its sublineages, has weakened the effectiveness of existing vaccines and antiviral drugs, underscoring the potential risk of future coronavirus pandemics. In response, a joint researc

The first clinical trial of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo is underway, the WHO said Tuesday.

There are more than 3,000 conditions in dermatology, experts warn – and chatbots’ recommendations can be flaky Read more in the Antiviral seriesWho among us has not, in a moment of panic or curiosity, consulted the internet in search of solutions to a medical ailment?Increasingly

Researchers have uncovered an unexpected antiviral defense system in sea anemones that works very differently from the one humans use. The discovery suggests evolution developed multiple ways to combat viruses, challenging long-held ideas about how animal immune systems evolved.

Um estudo mostrou que anêmonas-do-mar usam uma estratégia antiviral inesperada: uma proteína parecida com peça central da imunidade humana atua de forma oposta, mas ainda é essencial para barrar vírus. A descoberta amplia o que se sabia sobre a evolução das defesas contra infecções.